# Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)

> **NCT07629986** · — · RECRUITING · sponsor: **Fondation Ildys** · enrollment: 30 (estimated)

## Conditions studied

- Cystic Fibrosis (CF)
- Pulmonary Exacerbation
- Respiratory Infection Bacterial

## Interventions

- **OTHER:** No intervention assigned

## Key facts

- **NCT ID:** NCT07629986
- **Lead sponsor:** Fondation Ildys
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-19
- **Primary completion:** 2028-03
- **Final completion:** 2028-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07629986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07629986, "Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07629986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*